Evidence map›Paper›PMID 36030342›Full record

ArticleEuropean child & adolescent psychiatry2023

Killing pain?: a population-based registry study of the use of prescription analgesics, anxiolytics, and hypnotics among all children, adolescents and young adults in Norway from 2004 to 2019.

Helle Stangeland, Marte Handal, Svetlana Ondrasova Skurtveit, Helene Flood Aakvaag, Grete Dyb, Tore Wentzel-Larsen, Monica Baumann-Larsen, John Anker Zwart, Kjersti Storheim, Synne Øien Stensland

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in European child & adolescent psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04336605 (Killing Pain - Use of Analgesic, Sedative and Anxiolytic Medication and the Development of Psychiatric Illness in Adolescents), which is not on this map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04336605 unknown statusnot on this map

Killing Pain - Use of Analgesic, Sedative and Anxiolytic Medication and the Development of Psychiatric Illness in Adolescents

Typeobservational_patient_registrySponsorNorwegian Center for Violence and Traumatic Stress StudiesRan2020 to 2025Enrolled25,000ConditionsPTSD, Psychiatric Illness, Prescription Drug Dependence, AddictionArmsAge & Development, Socioeconomy, Traumatic Events, Psychosocial conditions, Lifestyle
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Youths' mental health care in the 21European child & adolescent psychiatry · 2025
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Helle StangelandNorwegian Centre for Violence and Traumatic Stress Studies (NKVTS), Gullhaugveien 1, 0484, Oslo, Norway. h.h.stangeland@nkvts.no.ORCID http://orcid.org/0000-0001-8609-9926
Marte HandalDepartment of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway.ORCID http://orcid.org/0000-0003-1773-0184
Svetlana Ondrasova SkurtveitDepartment of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway.ORCID http://orcid.org/0000-0001-7525-9701
Helene Flood AakvaagNorwegian Centre for Violence and Traumatic Stress Studies (NKVTS), Gullhaugveien 1, 0484, Oslo, Norway.ORCID http://orcid.org/0000-0003-4869-6038
Grete DybNorwegian Centre for Violence and Traumatic Stress Studies (NKVTS), Gullhaugveien 1, 0484, Oslo, Norway.ORCID http://orcid.org/0000-0002-7138-3665
Tore Wentzel-LarsenNorwegian Centre for Violence and Traumatic Stress Studies (NKVTS), Gullhaugveien 1, 0484, Oslo, Norway.ORCID http://orcid.org/0000-0002-0318-4162
Monica Baumann-LarsenDivision of Clinical Neuroscience, Department of Research and Innovation, Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0001-9688-416X
John Anker ZwartDivision of Clinical Neuroscience, Department of Research and Innovation, Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0001-5721-0154
Kjersti StorheimDivision of Clinical Neuroscience, Department of Research and Innovation, Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0002-6887-6901
Synne Øien StenslandNorwegian Centre for Violence and Traumatic Stress Studies (NKVTS), Gullhaugveien 1, 0484, Oslo, Norway.ORCID http://orcid.org/0000-0002-4462-3969
Oslo University Hospital · NONorwegian Centre for Violence and Traumatic Stress Studies · NONorwegian Institute of Public Health · NOUniversity of Oslo · NO

Funding

Dam Foundation 2020/FO283043
6 · The paper itself

Abstract

The ongoing opioid epidemic has been a global concern for years, increasingly due to its heavy toll on young people's lives and prospects. Few studies have investigated trends in use of the wider range of drugs prescribed to alleviate pain, psychological distress and insomnia in children, adolescents and young adults. Our aim was to study dispensation as a proxy for use of prescription analgesics, anxiolytics and hypnotics across age groups (0-29 years) and sex over the last 15 years in a large, representative general population. The study used data from a nationwide prescription database, which included information on all drugs dispensed from any pharmacy in Norway from 2004 through 2019. Age-specific trends revealed that the prevalence of use among children and adolescents up to age 14 was consistently low, with the exception of a substantial increase in use of melatonin from age 5. From age 15-29, adolescents and young adults used more prescription drugs with increasing age at all time points, especially analgesics and drugs with higher potential for misuse. Time trends also revealed that children from age 5 were increasingly dispensed melatonin over time, while adolescents from age 15 were increasingly dispensed analgesics, including opioids, gabapentinoids and paracetamol. In contrast, use of benzodiazepines and z-hypnotics slightly declined in young adults over time. Although trends were similar for both sexes, females used more prescription drugs than their male peers overall. The upsurge in use of prescription analgesics, anxiolytics and hypnotics among young people is alarming.Trial registration The study is part of the overarching Killing Pain project. The rationale behind the Killing Pain research was pre-registered through ClinicalTrials.gov on April 7, 2020. Registration number NCT04336605; https://clinicaltrials.gov/ct2/show/record/NCT04336605 .

Indexed as

Anti-Anxiety AgentsMelatoninPrescription DrugsAdolescentAdultAnalgesicsAnalgesics, OpioidChildChild, PreschoolDrug PrescriptionsFemaleHumansHypnotics and SedativesInfantInfant, NewbornMaleAnalgesicsAnalgesics, OpioidAnti-Anxiety AgentsHypnotics and SedativesMelatoninPrescription DrugsAnxietyPainPharmaco-epidemiologyPrescription drugsSleep

Identifiers

PMID36030342
PMCPMC9419914
OpenAlexW4293348902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.